Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 30 Mar 2023

Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Zhixin Liu
Shuai Chen
Wenming Jia
Ye Qian
Xiaoqi Yang
Minfa Zhang
Tianhe Fang
Heng Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1113781

3,271 views
5 citations

Original Research

Published on 30 Mar 2023

Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis

in Cancer Immunity and Immunotherapy

Xiushen Li
Xi Yang
Weiqi Xue
Rui Yang
Zhiwei He
Lisha Ai
Hui Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1119763

2,911 views
4 citations

Original Research

Published on 29 Mar 2023

Somatic and germline aberrations in homologous recombination repair genes in Chinese prostate cancer patients

in Cancer Immunity and Immunotherapy

Yixiao Liu
Bo Jin
Cheng Shen
Xianshu Gao
Xin Qi
Mingwei Ma
Hongzhen Li
Han Hao
Qi Tang
Kaiwei Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1086517

3,546 views
5 citations

Correction

Published on 29 Mar 2023

Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Yurong Peng
Zhuo Li
Yucheng Fu
Yue Pan
Yue Zeng
Junqi Liu
Chaoyue Xiao
Yingzhe Zhang
Yahui Su
Guoqing Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1163376

1,426 views
1 citation

Review

Published on 29 Mar 2023

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective

in Cancer Immunity and Immunotherapy

Ying Li
Shuai Xiang
Wenjun Pan
Jing Wang
Hanxiang Zhan
Shanglong Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1166860

7,647 views
34 citations

Systematic Review

Published on 24 Mar 2023

Effectiveness of immunosuppressant use for the treatment of immune checkpoint inhibitor-induced liver injury: A systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Kefan Chen
Junhao He
Jing Xu
Jie Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1088741

3,021 views
7 citations

Review

Published on 24 Mar 2023

Diet-gut microbial interactions influence cancer immunotherapy

in Cancer Immunity and Immunotherapy

Xue Wang
Shitao Geng

Frontiers in Oncology

doi 10.3389/fonc.2023.1138362

4,171 views
12 citations

Original Research

Published on 24 Mar 2023

Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells

in Cancer Immunity and Immunotherapy

Marine Potez
Sebastian Snedal
Chunhua She
Jongmyung Kim
Konrad Thorner
Timothy H. Tran
Maria Cecilia Ramello
Daniel Abate-Daga
James K. C. Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1124272

8,381 views
3 citations

Original Research

Published on 23 Mar 2023

Tim3 and PD-1 as a therapeutic and prognostic targets in colorectal cancer: Relationship with sidedness, clinicopathological parameters, and survival

in Cancer Immunity and Immunotherapy

Zahra Mokhtari
Marzieh Rezaei
Mohammad Hossein Sanei
Amirreza Dehghanian
Zahra Faghih
Zahra Heidari
Shirin Tavana

Frontiers in Oncology

doi 10.3389/fonc.2023.1069696

3,165 views
13 citations

Original Research

Published on 22 Mar 2023

Risk factors of temperature increase after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy

in Cancer Immunity and Immunotherapy

Hui-xia Kang
Jun-ying Ma
Yan-yan Su
Shan Kang
Bao-jie Feng
Xiao-bei Feng
Xu-sha Wang
Yun-yun Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1120499

2,068 views
2 citations

Original Research

Published on 21 Mar 2023

An immune infiltration-related prognostic model of kidney renal clear cell carcinoma with two valuable markers: CAPN12 and MSC

in Cancer Immunity and Immunotherapy

Guang Xia
Song Wu
Xiaoyu Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1161666

2,524 views

Original Research

Published on 17 Mar 2023

Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy

in Cancer Immunity and Immunotherapy

Demis N. Lipe
Aiham Qdaisat
Patrick Chaftari
Monica K. Wattana
Pavitra P. Krishnamani
Cielito Reyes-Gibby
Sai-Ching J. Yeung

Frontiers in Oncology

doi 10.3389/fonc.2023.1122329

2,269 views
3 citations

Review

Published on 17 Mar 2023

SMC4, a novel tumor prognostic marker and potential tumor therapeutic target

in Cancer Immunity and Immunotherapy

Zonglei Zhao
Xixiu Wang
Yan Ding
Xuefeng Cao
Xingyuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1117642

4,671 views
8 citations

Review

Published on 17 Mar 2023

Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?

in Cancer Immunity and Immunotherapy

Xiaoni Gao
Chengcheng Hong
Yang Xie
Xiangtai Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1103147

5,185 views
6 citations

Original Research

Published on 16 Mar 2023

Cuproplasia characterization in colon cancer assists to predict prognosis and immunotherapeutic response

in Cancer Immunity and Immunotherapy

Bomiao Zhang
Yien Li
Liqiang Song
Hua Xi
Shaoke Wang
Chenfeng Yu
Binbin Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1061084

3,135 views
6 citations

Original Research

Published on 16 Mar 2023

Cuproptosis signature and PLCD3 predicts immune infiltration and drug responses in osteosarcoma

in Cancer Immunity and Immunotherapy

Hai Hu
Yuesong Yin
Binbin Jiang
Zhennan Feng
Ting Cai
Song Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1156455

4,803 views
11 citations